1. Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial1. Issue 1 (9th June 2016) Authors: Girard, PM; Antinori, A; Arribas, JR; Ripamonti, D; Bicer, C; Netzle‐Sveine, B; Hadacek, B; Moecklinghoff, C Journal: HIV medicine Issue: Volume 18:Issue 1(2017:Jan.) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗